Company intelligence / Profile preview
Advaite Inc.
Malvern, Pennsylvania, United Statesadvaite.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Advaite has developed rapid point-of-care diagnostic kits for COVID‑19 using immunochromatography to detect IgM/IgG antibodies, aiming at mass screening. The company also holds an exclusive license option on a novel AMES Negative HDAC6 inhibitor from George Washington University targeting cancer. No published clinical results were found in the search results.
- Therapeutic areas
- Infectious DiseasesOncologyOther
- Modalities
- Small molecules (HDAC6 inhibitor)Point-of-care diagnostics (immunochromatography-based tests)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Exclusive license option agreement with The George Washington University for novel HDAC6 inhibitor technology
Beyond the preview
Go deeper on Advaite Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Advaite Inc..